Brief: Resonance Health Says United States Food & Drug Administration Grants 510(K) Clearance For Liversmart
30/12/2021 24:11
Dec 30 (Reuters) - Resonance Health:
* UNITED STATES FOOD & DRUG ADMINISTRATION GRANTS 510(K)
CLEARANCE
FOR LIVERSMART
* FDA CLEARANCE ALLOWS LIVERSMART, TO BE COMMERCIALLY
MARKETED AND
SOLD IN UNITED STATES OF AMERICA
Source text for Eikon: ID:nASX7stGdx
Further company coverage: RHT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Resonance Health
See all newsBrief: Resonance Health Halts Trading In Resonance Health Securities Pending Announcement
Australia's Resonance Health gains on IAG agreement
Brief: Resonance Health Enters Global Strategic Alliance & MSA With Image Analysis Group
Brief: Resonance Health Posts Profit Attributable Of A$1.5 Million
Brief: Resonance Health Says It Expects FY27 Normalised EBITDA Of AUD 2.6 To 3.6 Million